Mark Savaya Acknowledges Expanding Research Focus on Plant-Based Medicine

Advancing Cannabis Science: Pioneering Research and Quality Standards
In recent years, leading research institutions have explored the potential therapeutic properties of certain cannabis compounds. Yale University researchers have examined non-intoxicating cannabinoids for their possible role in managing chronic pain, while noting that more evidence is needed to determine their safety and effectiveness in humans [1].
Broader public health research also reflects a growing shift in perceptions. A federally funded study published in the Journal of the American Medical Association (JAMA) found correlations between states with medical cannabis laws and a reduction in prescribed opioid dosages, though the authors cautioned that causality could not be confirmed and more controlled research is needed [2].
Savaya has expressed that these developments highlight the importance of continued, evidence-based research into plant-derived compounds and responsible public education. His focus remains on promoting informed dialogue around wellness innovations supported by scientific inquiry and regulatory oversight.
Nicole Adams
Gold Dot Media
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.